使用孟德尔的随机化,探索塔卡亚苏动脉炎和炎症性肠病之间的因果关系
Xiaoli Pang1, Huizhong Yang1, Chi Wang2
1Department of Pediatric Gastroenterology, Children's Medical Center, The First Hospital of Jilin University, Changchun, Jilin, 130021, China.
Immunologic research
|March 27, 2024
概括
这项研究使用孟德尔的随机化研究,调查了塔卡亚苏动脉炎 (TA) 和炎症性肠病 (IBD) 之间的潜在因果关系. 研究结果表明,TA可能是克罗恩病的危险因素,因此需要进一步研究这一关联.
科学领域:
- 遗传学 遗传学 是一个
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
背景情况:
- 塔卡亚苏动脉炎 (TA) 和炎症性肠病 (IBD) 是不同的疾病,观察到并发症.
- 在TA患者中,IBD的发病率明显高于一般人群,这表明存在潜在的联系.
- 门德尔随机化 (MR) 是一种强大的方法,通过利用遗传变异推断因果关系,减轻混和反向因果关系.
研究的目的:
- 通过两样本的门德尔随机分析,研究高山脉炎 (TA) 和炎症性肠病 (IBD) 之间的潜在因果关系.
- 探索TA是否因果关系影响IBD发展风险,包括其主要亚型,克罗恩病 (CD) 和性结肠炎 (UC).
主要方法:
- 使用TA和IBD的总结GWAS数据进行了两样本的门德尔随机化 (MR) 分析.
- 与TA相关的遗传变异被用作工具变量,以评估它们对IBD风险的因果影响.
- 进行了敏感性分析,包括MR-Egger回归,Cochran的Q测试和离开一个的分析,以评估异质性和性.
主要成果:
- 虽然主要的IVW方法显示了TA增加IBD风险的非显著趋势 (OR=1.053,P=0.065),但加权中位数 (OR=1.038,P=0.002) 和加权模式 (OR=1.051,P=0.009) 方法表明了显著的有害因果作用.
- 对克罗恩病 (CD) 的分层分析显示了与三种MR方法的显著关联,表明TA是危险因素 (IVWOR=1.045,P=0.032;加权中位数OR=1.028,P=0.021;加权模式OR=1.031,P=0.022).
- 没有观察到TA对性结肠炎 (UC) 的显著因果关系.
结论:
- 这项研究提供了初步证据,表明Takayasu动脉炎 (TA) 在炎症性肠病 (IBD) 的发展中可能起因作用.
- 具体而言,研究结果表明,TA可能起到克罗恩病 (CD) 的贡献风险因素的作用.
- 需要进一步的研究来阐明连接TA和CD的潜在机制.
相关概念视频
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
179
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
179
01:30Inflammatory Bowel Disease II: Crohn's Disease
233
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
233
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
01:17Chronic Bowel Disorders: Introduction
450
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
450
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
137
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
137
01:29Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127